TransCode Therapeutics Inc
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From TransCode Therapeutics Inc
Public Company Edition: Three $100m-plus US initial public offerings launched on 15 July after two smaller biopharma IPOs earlier in the month. Also, Gelesis announced a SPAC merger, Brii and Amniotics launched ex-US IPOs, and Intellia, Cerevel and Kymera priced large follow-on offerings.
- In Vitro Diagnostics
- Drug Delivery
- Radiopharmaceuticals, Contrast Agents
- Antisense, Oligonucleotides
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.